Following new concerns about potential side effects, Alexandria and statewide health administrations are pausing all planned Johnson & Johnson vaccinations.
The news comes after the CDC and the FDA released a recommendation to stop using the vaccine after six patients reportedly developed a rare and severe type of blood clot.
According to the Alexandria Health Department:
Based on federal and state guidance, Alexandria Health Department and other vaccinating providers in Virginia are pausing the use of Johnson & Johnson vaccines immediately. Individuals with existing appointments will be contacted to either reschedule their appointment or receive a vaccine from a different manufacturer, based on available supplies. Updates will be shared as they become available.
The city recently moved into Phase 2 of vaccination efforts and aims to vaccinate at least 80% of the city’s adult population. Currently 20% (30,975 residents) are fully vaccinated and 1/3 are partially vaccinated (53,757 residents).
Based on federal guidance, Alexandria Health Department and other vaccinators in Virginia are pausing the use of Johnson & Johnson vaccines. Individuals with appointments will be contacted to reschedule or receive a different vaccine, based on supply. https://t.co/6YSY9fa1PZ.
— AlexandriaVAGov (@AlexandriaVAGov) April 13, 2021
Recent Stories
What an unexpectedly busy summer week in Alexandria. Here’s the rundown. Our top story was on an Alexandria woman who claims she was roofied at a restaurant on the waterfront…
A special insert to the Washington Post print edition today features a comic book adaptation of Alexandria track star Noah Lyles’ life. The twenty-page comic book is accompanied by a…
(Updated 1:25 p.m.) Southbound drivers on Beauregard Street were forced to find a detour around noon today (Friday) after a burning garbage truck closed southbound lanes at the intersection with…
In this week’s Just Listed, find a 3 BD/2 BA updated Warwick Village home, complete with a large rec room, patio and manicured outdoor space.
